Literature DB >> 30851660

Affective vulnerability in substance use disorders.

R Kathryn McHugh1, Elizabeth T Kneeland2.   

Abstract

Substances of abuse are characterized by their rewarding effects and engagement of reward pathways in the brain. However, these substances also provide rapid relief of negative affect, and thus are highly negatively reinforcing. Accordingly, negative affectivity and other affective vulnerabilities (factors related to the experience of affect) are strongly linked to problematic substance use and substance use disorders. In this review, we provide a critical overview of the literature on affective vulnerabilities in substance use disorders. We discuss how both the experience of affect (e.g. negative affectivity, stress reactivity) and the interpretation of affect (e.g. distress intolerance, anxiety sensitivity) are pertinent to the development, maintenance, and treatment of substance use disorders.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30851660      PMCID: PMC6661223          DOI: 10.1016/j.copsyc.2019.01.011

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  56 in total

1.  Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility.

Authors:  Stacey B Daughters; C W Lejuez; Marina A Bornovalova; Christopher W Kahler; David R Strong; Richard A Brown
Journal:  J Abnorm Psychol       Date:  2005-11

2.  Anxiety sensitivity and illicit sedative use among opiate-dependent women and men.

Authors:  Bridget A Hearon; Amanda W Calkins; Daniella M Halperin; R Kathryn McHugh; Heather W Murray; Michael W Otto
Journal:  Am J Drug Alcohol Abuse       Date:  2010-11-19       Impact factor: 3.829

3.  Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence.

Authors:  Alan D Sirota; Damaris J Rohsenow; Selene V Mackinnon; Rosemarie A Martin; Cheryl A Eaton; Gary B Kaplan; Peter M Monti; Jennifer W Tidey; Robert M Swift
Journal:  Addict Behav       Date:  2010-03-02       Impact factor: 3.913

4.  Behavioral arousal in response to stress and drug cue in alcohol and cocaine addicted individuals versus healthy controls.

Authors:  Tara M Chaplin; Kwangik Hong; Helen C Fox; Kristen M Siedlarz; Keri Bergquist; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2010-07       Impact factor: 1.672

5.  Domain-general and domain-specific strategies for the assessment of distress intolerance.

Authors:  R Kathryn McHugh; Michael W Otto
Journal:  Psychol Addict Behav       Date:  2011-08-08

6.  Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Robert H Pietrzak; Risë B Goldstein; Steven M Southwick; Bridget F Grant
Journal:  J Anxiety Disord       Date:  2010-11-26

7.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

8.  Changes in distress intolerance and treatment outcome in a partial hospital setting.

Authors:  R Kathryn McHugh; Sarah J Kertz; Rachel B Weiss; Arielle R Baskin-Sommers; Bridget A Hearon; Thröstur Björgvinsson
Journal:  Behav Ther       Date:  2013-11-13

9.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28

10.  Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Authors:  Sharaf S Khan; Roberto Secades-Villa; Mayumi Okuda; Shuai Wang; Gabriela Pérez-Fuentes; Bradley T Kerridge; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2012-11-22       Impact factor: 4.492

View more
  12 in total

1.  Decreased reward-related brain function prospectively predicts increased substance use.

Authors:  Corinne P Bart; Robin Nusslock; Tommy H Ng; Madison K Titone; Ann L Carroll; Katherine S F Damme; Christina B Young; Casey C Armstrong; Jason Chein; Lauren B Alloy
Journal:  J Abnorm Psychol       Date:  2021-11

2.  Anxiety Sensitivity as a Malleable Mechanistic Target for Prevention Interventions: A Meta-Analysis of the Efficacy of Brief Treatment Interventions.

Authors:  Hayley E Fitzgerald; Danielle L Hoyt; M Alexandra Kredlow; Jasper A J Smits; Norman B Schmidt; Donald Edmondson; Michael W Otto
Journal:  Clin Psychol (New York)       Date:  2021-10-21

3.  Stress and Affect as Daily Risk Factors for Substance Use Patterns: an Application of Latent Class Analysis for Daily Diary Data.

Authors:  Ashley N Linden-Carmichael; Natalia Van Doren; Bethany C Bray; Kristina M Jackson; Stephanie T Lanza
Journal:  Prev Sci       Date:  2021-10-30

4.  Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients.

Authors:  Giovanni Martinotti; Attilio Negri; Stefania Schiavone; Chiara Montemitro; Chiara Vannini; Gaia Baroni; Mauro Pettorruso; Fabio De Giorgio; Raffaele Giorgetti; Valeria Verrastro; Luigia Trabace; Andres Garcia; Ivan Castro; Juan Iglesias Lopez; Cristina Merino Del Villar; Fabrizio Schifano; Massimo di Giannantonio
Journal:  Front Psychiatry       Date:  2020-08-31       Impact factor: 4.157

5.  Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.

Authors:  Corey R Roos; Brian D Kiluk; R Kathryn McHugh; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2020-04-16

6.  Dampening of Positive Affect Predicts Substance Use During Partial Hospitalization.

Authors:  Andrew D Peckham; R Kathryn McHugh; Elizabeth T Kneeland; Thröstur Björgvinsson; Courtney Beard
Journal:  Cognit Ther Res       Date:  2020-04-17

7.  Amphetamine and the Smart Drug 3,4-Methylenedioxypyrovalerone (MDPV) Induce Generalization of Fear Memory in Rats.

Authors:  Paola Colucci; Giulia Federica Mancini; Alessia Santori; Clemens Zwergel; Antonello Mai; Viviana Trezza; Benno Roozendaal; Patrizia Campolongo
Journal:  Front Mol Neurosci       Date:  2019-11-29       Impact factor: 5.639

8.  Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder.

Authors:  Kirsten J Langdon; Susan Ramsey; Caroline Scherzer; Kate Carey; Megan L Ranney; Josiah Rich
Journal:  Addict Sci Clin Pract       Date:  2020-04-29

Review 9.  Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings.

Authors:  Lynn M Oswald; Kelly E Dunn; David A Seminowicz; Carla L Storr
Journal:  J Pers Med       Date:  2021-04-19

Review 10.  Cognitive-Affective Transdiagnostic Factors Associated With Vulnerability to Alcohol and Prescription Opioid Use in the Context of Pain.

Authors:  Emily L Zale; Jessica M Powers; Joseph W Ditre
Journal:  Alcohol Res       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.